[1]Ramachandran A, Ma RC,Snehalatha C. Diabetes in Asia. Lancet. 2010 Jan 30;375(9712):408-18.
[2]Nanditha A, Ma RC, Ramachandran A, et al. Diabetes in Asia and the Pacific: Implications for the GlobalEpidemic. Diabetes Care.2016 Mar;39(3):472-85.
[3]Ashcroft FM, Rorsman P. Diabetes mellitus and the β cell: the last ten years.Cell. 2012 Mar16;148(6):1160-71.
[4]Eisenbarth GS. Type l diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986 May22;314(21):1360-8.
[5]Ma RCW. Epidemiology of diabetes and diabetic complications in China. Diabetologia. 2018Jun;61(6):1249-1260.
[6]Reversing the rising tide of diabetes in China. Lancet. 2016 Nov 26;388(10060);2566.
[7]Sudesna Chatterjee,Kamlesh Khunti,Melanie J Davies. Type 2 diabetes. Lancet. 2017.10.1016/S0140-6736(17)30058-2
[8]宁光.中国糖尿病防治的现状及展望(2019)。
[9]Ren M, Lin DZ, Liu ZP, et al. Potential Novel Serum Metabolic Markers Associated with Progression ofPrediabetes to Overt Diabetes in a Chinese Population. Front Endocrinol (Lausanne). 2022 Jan5;12:745214.
[10]Wang S,Li M, Lin H, et al. Amino acids, microbiota-related metabolites, and the risk ofincident diabe-tes among normoglycemic Chinese adults: Findings from the 4C study.Cell Rep Med.2022 Aug 17:100727.
[11]Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes.Nature. 2012 Oct 4;490(7418):55-60.
